Literature DB >> 24256230

The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus.

Rebecca M Terns1, Michael P Terns.   

Abstract

Using the hyperthermophile Pyrococcus furiosus, we have delineated several key steps in CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) invader defence pathways. P. furiosus has seven transcriptionally active CRISPR loci that together encode a total of 200 crRNAs (CRISPR RNAs). The 27 Cas proteins in this organism represent three distinct pathways and are primarily encoded in two large gene clusters. The Cas6 protein dices CRISPR locus transcripts to generate individual invader-targeting crRNAs. The mature crRNAs include a signature sequence element (the 5' tag) derived from the CRISPR locus repeat sequence that is important for function. crRNAs are tailored into distinct species and integrated into three distinct crRNA-Cas protein complexes that are all candidate effector complexes. The complex formed by the Cmr [Cas module RAMP (repeat-associated mysterious proteins)] (subtype III-B) proteins cleaves complementary target RNAs and can be programmed to cleave novel target RNAs in a prokaryotic RNAi-like manner. Evidence suggests that the other two CRISPR-Cas systems in P. furiosus, Csa (Cas subtype Apern) (subtype I-A) and Cst (Cas subtype Tneap) (subtype I-B), target invaders at the DNA level. Studies of the CRISPR-Cas systems from P. furiosus are yielding fundamental knowledge of mechanisms of crRNA biogenesis and silencing for three of the diverse CRISPR-Cas pathways, and reveal that organisms such as P. furiosus possess an arsenal of multiple RNA-guided mechanisms to resist diverse invaders. Our knowledge of the fascinating CRISPR-Cas pathways is leading in turn to our ability to co-opt these systems for exciting new biomedical and biotechnological applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256230      PMCID: PMC3996508          DOI: 10.1042/BST20130056

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  43 in total

1.  The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes.

Authors:  James S Godde; Amanda Bickerton
Journal:  J Mol Evol       Date:  2006-04-11       Impact factor: 2.395

2.  A putative viral defence mechanism in archaeal cells.

Authors:  Reidun K Lillestøl; Peter Redder; Roger A Garrett; Kim Brügger
Journal:  Archaea       Date:  2006-08       Impact factor: 3.273

3.  Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.

Authors:  Takuo Osawa; Hideko Inanaga; Tomoyuki Numata
Journal:  J Mol Biol       Date:  2013-04-10       Impact factor: 5.469

4.  Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage.

Authors:  Ruiying Wang; Gan Preamplume; Michael P Terns; Rebecca M Terns; Hong Li
Journal:  Structure       Date:  2011-02-09       Impact factor: 5.006

5.  Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.

Authors:  Alexander Bolotin; Benoit Quinquis; Alexei Sorokin; S Dusko Ehrlich
Journal:  Microbiology       Date:  2005-08       Impact factor: 2.777

6.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

7.  Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex.

Authors:  Yaming Shao; Alexis I Cocozaki; Nancy F Ramia; Rebecca M Terns; Michael P Terns; Hong Li
Journal:  Structure       Date:  2013-02-07       Impact factor: 5.006

8.  Sequence- and structure-specific RNA processing by a CRISPR endonuclease.

Authors:  Rachel E Haurwitz; Martin Jinek; Blake Wiedenheft; Kaihong Zhou; Jennifer A Doudna
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

9.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

10.  A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action.

Authors:  Kira S Makarova; Nick V Grishin; Svetlana A Shabalina; Yuri I Wolf; Eugene V Koonin
Journal:  Biol Direct       Date:  2006-03-16       Impact factor: 4.540

View more
  16 in total

1.  Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus.

Authors:  Tong Guo; Wenyuan Han; Qunxin She
Journal:  RNA Biol       Date:  2018-07-09       Impact factor: 4.652

2.  Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci.

Authors:  Masami Shiimori; Sandra C Garrett; Brenton R Graveley; Michael P Terns
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

3.  Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.

Authors:  Sonali Majumdar; Marianne Ligon; William Colby Skinner; Rebecca M Terns; Michael P Terns
Journal:  Extremophiles       Date:  2016-08-31       Impact factor: 2.395

4.  A journey down to hell: new thermostable protein-tags for biotechnology at high temperatures.

Authors:  Rosanna Mattossovich; Rosa Merlo; Angelo Fontana; Giuliana d'Ippolito; Michael P Terns; Elizabeth A Watts; Anna Valenti; Giuseppe Perugino
Journal:  Extremophiles       Date:  2019-09-25       Impact factor: 3.035

5.  Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.

Authors:  Sonali Majumdar; Peng Zhao; Neil T Pfister; Mark Compton; Sara Olson; Claiborne V C Glover; Lance Wells; Brenton R Graveley; Rebecca M Terns; Michael P Terns
Journal:  RNA       Date:  2015-04-22       Impact factor: 4.942

6.  An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.

Authors:  Wenfang Peng; Mingxia Feng; Xu Feng; Yun Xiang Liang; Qunxin She
Journal:  Nucleic Acids Res       Date:  2014-12-10       Impact factor: 16.971

7.  DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus.

Authors:  Joshua Elmore; Trace Deighan; Jan Westpheling; Rebecca M Terns; Michael P Terns
Journal:  Nucleic Acids Res       Date:  2015-10-30       Impact factor: 16.971

8.  Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity.

Authors:  Kawanda Foster; Sabine Grüschow; Scott Bailey; Malcolm F White; Michael P Terns
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

Review 9.  Diversity of CRISPR-Cas immune systems and molecular machines.

Authors:  Rodolphe Barrangou
Journal:  Genome Biol       Date:  2015-11-09       Impact factor: 13.583

Review 10.  CRISPR-Cas systems: new players in gene regulation and bacterial physiology.

Authors:  Timothy R Sampson; David S Weiss
Journal:  Front Cell Infect Microbiol       Date:  2014-04-04       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.